Literature DB >> 2786616

Clinical presentation of Graves' ophthalmopathy.

W M Wiersinga1, T Smit, R van der Gaag, M Mourits, L Koornneef.   

Abstract

The eye findings of Graves' ophthalmopathy were prospectively recorded in 90 consecutive untreated patients (66 females, 24 males; mean age 44.5 years) according to the 1977 NOSPECS classification. Soft-tissue involvement was observed in 90%, proptosis greater than or equal to 23 mm in 30%, eye muscle involvement in 60%, corneal involvement in 9% and sight loss in 34%. No differences in the distribution of eye changes between right and left eye were found. Values for proptosis (mean +/- SD, 20.2 +/- 3.6 mm) had a near-normal distribution. Orbital computed tomography (CT) scanning (performed in 80 cases) demonstrated enlargement of inferior rectus in 60%, medial rectus in 50%, superior rectus in 40% and lateral rectus in 22%. Unilateral eye disease was present in 13 patients (14%); in 4 of these patients the CT scan showed eye muscle enlargement also in the fellow eye and in 2 patients bilateral eye disease subsequently developed. The distribution of age, sex and NOSPECS classes in patients with unilateral eye disease was similar to that in patients with bilateral eye disease, but the interval between the onset of thyroid and eye disease was much shorter in cases of unilateral than in cases of bilateral eye disease. Patients without clinically evident thyroid disease (n = 20, 22%) were not different from patients with thyroid disease in age, sex or ophthalmological presentation. The various data suggest: (1) the 1977 NOSPECS classification under-represents significant proptosis in 12% of cases; (2) the age and sex distribution of patients with Graves' ophthalmopathy is similar to that of cases with thyroidal Graves' disease, and (3) unilateral Graves' ophthalmopathy may represent an early stage of the disease, that as a rule already is or develops shortly afterwards into a bilateral disease.

Entities:  

Mesh:

Year:  1989        PMID: 2786616     DOI: 10.1159/000266782

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  28 in total

1.  Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression.

Authors:  A K Eckstein; B Quadbeck; S Tews; K Mann; C Krüger; C H Mohr; K-P Steuhl; J Esser; R K Gieseler
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

2.  Thyroid-associated orbitopathy.

Authors:  Adel H Alsuhaibani; Jeffrey A Nerad
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

3.  The permeability of the corneal epithelium of Graves' ophthalmopathy as determined by fluorophotometry.

Authors:  H A Khalil; J A van Best; R J de Keizer
Journal:  Doc Ophthalmol       Date:  1989-11       Impact factor: 2.379

4.  Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.

Authors:  A Barth; P Probst; H Bürgi
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

5.  The current role of radiotherapy in "Bilateral exophthalmos in Grave's Disease".

Authors:  S Stylianidou; P Bousbouras; I Tzitzikas; K Pistevou-Gombaki
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

6.  Hyperthyroid vs hypothyroid eye disease: the same severity and activity.

Authors:  M B Kashkouli; F Pakdel; V Kiavash; I Heidari; A Heirati; S Jam
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

Review 7.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 8.  Thyroid eye disease.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

9.  Regression of Ophthalmopathic Exophthalmos in Graves' Disease After Total Thyroidectomy: a Prospective Study of a Surgical Series.

Authors:  P R K Bhargav; M Sabaretnam; S Chandra Kumar; S Zwalitha; N Vimala Devi
Journal:  Indian J Surg       Date:  2016-06-22       Impact factor: 0.656

10.  Fat-removal orbital decompression for disfiguring proptosis associated with Graves' ophthalmopathy: safety, efficacy and predictability of outcomes.

Authors:  Emmy Y Li; Tracy Y Kwok; Andy C Cheng; Alex C Wong; Hunter K Yuen
Journal:  Int Ophthalmol       Date:  2014-04-29       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.